Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$2.9M
Net $2.0M sold
Sales
$2.0M
2 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Megna Michael R
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Oct 22, 2025
- Transaction Date
- Oct 20, 2025
- Accession Number
- 0001464583-25-000005
- Form Type
- 4
- Net Trading Amount
- -$2.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Oct 20, 2025 | Class A Ordinary Share | 791 | $15.50 | Exercise | $12.3K |
| Oct 20, 2025 | Class A Ordinary Share | 6,195 | $12.97 | Exercise | $80.3K |
| Oct 20, 2025 | Class A Ordinary Share | 9,831 | $11.10 | Exercise | $109.1K |
| Oct 20, 2025 | Class A Ordinary Share | 9,831 | $11.97 | Exercise | $117.7K |
| Oct 20, 2025 | Class A Ordinary Share | 12,787 | $10.76 | Exercise | $137.6K |
| Oct 20, 2025 | Class A Ordinary Share | 37,255 | $38.72 | Sale | $1.4M |
| Oct 20, 2025 | Class A Ordinary Share | 13,235 | $39.31 | Sale | $520.3K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Oct 20, 2025 | Derivative | 791 | $15.50 | Exercise | $12.3K |
| Oct 20, 2025 | Derivative | 6,195 | $12.97 | Exercise | $80.3K |
| Oct 20, 2025 | Derivative | 9,831 | $11.10 | Exercise | $109.1K |
| Oct 20, 2025 | Derivative | 9,831 | $11.97 | Exercise | $117.7K |
| Oct 20, 2025 | Derivative | 12,787 | $10.76 | Exercise | $137.6K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.14 and $39.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.145 and $39.57. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F4)The option is fully vested and exercisable.